Cumberland Pharmaceuticals Inc (CPIX)

Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2025-12-31	2025-09-30	2025-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	98.78%0.17	13.68	8.29	10.84	9.13
	0.77	-	-	-	-
Research and Development	0.77	-	-	-	-
Interest Income/Expense	99.36%0.00	0.11	0.11	0.11	0.09
Costs And Expenses	77.98%3.33	15.11	10.26	11.58	12.26
Operating Income/Loss	130.49%-3.16	-1.37	-1.97	-0.75	-3.13
Income/Loss From Continuing Operations Before Tax	117.01%-3.10	-1.43	-1.94	-0.73	1.25
Income Tax Expense/Benefit	83.35%0.00	0.02	0.01	0.01	0.00
Income/Loss From Continuing Operations After Tax	117.28%-3.10	-1.43	-1.95	-0.74	1.25
	199.20%-4.27	-1.43	-1.95	-0.74	-3.29
Attributable To Parent	202.93%-4.28	-1.41	-1.94	-0.74	-3.29
Attributable To Noncontrolling Interest	111.49%0.00	-0.02	-0.01	0.01	0.00
Basic Average Shares	15,183%14.98	-0.10	14.96	14.96	14.96
Diluted Average Shares	15,183%14.98	-0.10	14.96	14.96	14.96
Basic Earnings Per Share	222.22%-0.29	-0.09	-0.13	-0.05	-0.22
Diluted Earnings Per Share	222.22%-0.29	-0.09	-0.13	-0.05	-0.22